Function and Mechanism of Action
The pharmacokinetics of many drugs are based on their interaction with specialized transport systems. P-glycoprotein is an ATP-dependent transport protein (known as an efflux pump).
Its function differs fundamentally from mechanisms such as passive diffusion, paracellular transport, or receptor-mediated endocytosis. It is an exclusively active process: the protein uses the energy of ATP molecules to capture specific substances inside the cell and forcibly "pump" them back into the vascular lumen.
This mechanism is of particular importance for the blood-brain barrier (BBB). P-glycoprotein acts as a guard that limits the accumulation of a wide range of medicinal substances in brain tissue. Known substrates of this protein include digoxin, cyclosporine, domperidone, and loperamide.
Clinical Example: Loperamide
Let us examine how the pump works using a popular drug as an example.
From a pharmacodynamic perspective, loperamide is an opioid receptor agonist (it is important to remember that it is not an acetylcholinesterase inhibitor, an H1 receptor blocker, or an opioid antagonist). The therapeutic goal of its prescription is the treatment of diarrhea by reducing intestinal peristalsis.
The effect of loperamide is strictly peripheral. The question arises: why does the drug, being an opioid, not cause euphoria or respiratory depression? The answer lies in the function of the BBB:
- Normally, P-glycoprotein recognizes loperamide and actively prevents it from entering brain tissue.
- The continuous pumping of the drug back into the blood completely prevents the development of central side effects.
Dangerous Drug Interactions
The situation changes radically if the protective pump is disrupted. Certain medicinal substances act as P-glycoprotein inhibitors. Classic examples of such blockers are verapamil and quinidine.
What happens during concurrent administration:
- The inhibitor (e.g., verapamil) binds to P-glycoprotein and blocks its function.
- The transport protein stops pumping loperamide out of the endothelial cells.
- Loperamide begins to cross the blood-brain barrier unhindered.
- The accumulation of the opioid receptor agonist in the central nervous system leads to a high risk of severe adverse reactions (euphoria, profound respiratory depression).
Briefly: answers to topical questions
What other proteins of the ABC transporter family, besides P-glycoprotein, are involved in drug resistance?
In addition to P-glycoprotein, other efflux transport systems of the ATP-binding cassette family are involved in the development of drug resistance. These include:
- MRP1 — an alternative xenobiotic efflux system.
- BCRP — breast cancer resistance protein.
- MDRP2 — multidrug resistance protein 2.
These ATP-dependent transporters ensure the active export of drugs from the cell cytoplasm outward, resulting in a decrease in intracellular drug concentration and treatment failure.
In which organs and tissues, besides the blood-brain barrier, is P-glycoprotein expressed?
In addition to the blood-brain barrier, P-glycoprotein is localized in various normal and pathological tissues of the body. The anatomical expression of this transport protein includes:
- Enterocytes — intestinal cell membranes.
- Hepatocytes — liver cells.
- Epithelial cells (tubuli proximales) — renal tubule epithelium.
- Endothelial cells — cells of histohematic barriers.
- Tumor cells — malignant neoplasms that overexpress this protein to remove antitumor drugs (cytostatica).
Imagine P-glycoprotein as a strict bouncer at the entrance to an elite club (the brain). As soon as an unwanted guest (loperamide) crosses the threshold, the bouncer expends his energy (ATP) and throws him back onto the street (into the bloodstream). However, if the bouncer is distracted (given an inhibitor like verapamil), chaos ensues inside the club (central side effects).
Class and exam questions
Is transport by P-glycoprotein a passive process?
No. It is an active ATP-dependent transport process that requires energy expenditure to move substances.
Why is loperamide used for diarrhea without fearing opioid dependence?
Loperamide acts exclusively in the periphery. P-glycoprotein in the blood-brain barrier pumps it back into the blood, preventing it from entering the CNS and causing central effects.
What happens with the concurrent administration of loperamide and verapamil?
Verapamil will block P-glycoprotein, loperamide will penetrate the brain, causing severe CNS side effects (up to and including respiratory depression).
What else to study on this topic
- Structure and localization of ATP-dependent transport pumps in the body
- Pharmacokinetics of digoxin and cyclosporine: the role of P-glycoprotein
- Mechanisms of receptor-mediated endocytosis and passive diffusion
- Central and peripheral effects of opioid receptor agonists
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "The Role of P-glycoprotein" and 5,304 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in "General Pharmacology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.